Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04626232
Other study ID # RECHMPL20-0013 PROM 7925
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date September 12, 2022
Est. completion date November 30, 2022

Study information

Verified date May 2024
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the impact of the procedure (sleeve gastrectomy technique with a Nissen fundoplication (N-Sleeve) vs conventional sleeve gastrectomy technique


Description:

Bariatric surgery is recognized as the only effective therapeutic weapon for morbidly obese patients. Gastro-Oesophageal Reflux Disease is very common (30-45% of cases) with serious consequences on the oesophageal mucosa. It could be an exacerbation of preoperative GERD symptoms or a "de novo" postoperative GERD. Medical treatment is usually effective but reoperation may be required to treat refractory GERD.GERD can lead to serious consequences on the oesophageal mucosa (esophagitis, Barrett's oesophagus, cancer). The conventional surgical treatment of GERD is fundoplication, which can be partial or total. The gastric fundus is wrapped around the oesophagus to strengthen the tone of the oesophageal sphincter. We hypothesize that the creation of a total anti-reflux fundoplication before performing LSG (Nissen + Sleeve = N-sleeve) could significantly reduce the postoperative GERD complication as compared with the standard LSG. To evaluate the impact of the procedure N-Sleeve vs conventional sleeve gastrectomy technique on the rate of patient with GERD at 1, 6 and 12 months postoperatively. To evaluate the impact of the procedure (sleeve gastrectomy technique with a Nissen fundoplication (N-Sleeve) vs conventional sleeve gastrectomy technique during all the follow-up on the gastric fistula on the staple line, on the postoperative morbidity and mortality , on the evolution of weight loss, the excess weight loss, the BMI and the excess BMI loss during the follow-up. Evaluate the impact of these procedures on the quality of life of patients at baseline and 1, 6 and 12 months postoperatively. Evaluate the safety during all the follow-up. •Methods: Monocentric, randomized, single-blind controlled trial, with 2 parallel arms. 144 patients. The target population is all adult patients with severe or morbid obesity, who underwent multidisciplinary care and having the criteria of 2009 HAS recommendations for bariatric surgery. Presence of gastro-oesophageal reflux will be assessed by a composite criteria: consumption of Proton Pump Inhibitor and gastroscopy at baseline and 12-month. The N-SLEEVE technique consists of creating a gastric total fundoplication before to perform the removal of 2/3 of the stomach. This study may really lead to a change in terms of choice of first intention bariatric procedures.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date November 30, 2022
Est. primary completion date November 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Signed informed consent form - Subjects must be able to attend all scheduled visits and to comply with all trial procedures - Subjects must be covered by public health insurance - Contraception efficacy - Subjects eligible for sleeve gastrectomy after multidisciplinary evaluation according to HAS 2009 criteria: BMI = 40 kg / m² with failure of the dietary treatment for at least 1 year, or a BMI = 35kg / m² with at least one co-morbidity that could be improved after surgery (hypertension, obstructive sleep apnea hypopnea syndrome (OSAHS) and other severe respiratory disorders, severe metabolic disorders (especially type 2 diabetes), debilitating musculoskeletal diseases, non-alcoholic steato-hepatitis (NASH)) Exclusion Criteria: - Subject unable to read or/and write - Planned longer stay outside the region that prevents compliance with the visit plan - Current pregnancy - Previous bariatric surgery (ring, vertical banded gastroplasty, sleeve gastrectomy or Gastric Bypass). - BMI > 50 kg / m² for women and > 45kg / m² for men (dissecting the hiatus region can be a technical challenge in these cases). - Barrett oesophagus and esophagitis stage III and IV. - Funditis - Long-term NSAIDs and/or corticosteroid therapy - No affiliation at the French social security scheme. - Major protected by law. - Deprivation of liberty by judicial or administrative decision. - Participation to another clinical research program.

Study Design


Intervention

Procedure:
N-SLEEVE technique
The N-SLEEVE technique (figure 2) consists of creating a gastric total fundoplication (Nissen technique) before to perform the removal of 2/3 of the stomach (SLEEVE technique).
SLEEVE
SLEEVE Technique : Removal of 2/3 of the stomach

Locations

Country Name City State
France CHU Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence of gastroesophageal reflux disease Gastroscopy is a standard endoscopic examination that examines the lining of the oesophagus and stomach. It can detect Helicobacter pylori and highlight the presence of:
Gastro-Oesophageal Reflux Disease
Gastritis
Esophagitis
Barrett's oesophagus
Hiatal hernia
Gastric tumor
Bile reflux
Incompetent cardia
12 months
Primary Consumption of Proton Pump Inhibitor The consumption of PPI, revealing the presence of GERD symptoms, will be recorded at each visit thanks a diary card. 12 months
Secondary type of fistula Month 1 The diagnosis is confirmed by conducting a CT with contrast medium opacification. 4 stages are defined I, II, III and IV. TDM will be realized only in case of suspicion of fistulas (fever, pain in the left shoulder, vomiting).
The type, the severity and the time between the date of occurrence of fistula and the date of the surgery will be recorded at each visit.
Month 1
Secondary severity of fistula Month 1 The severity of fistula is classified depending on the classification of Montpellier 2013 (Nedelcu) Month 1
Secondary type of fistula Month 6 The diagnosis is confirmed by conducting a CT with contrast medium opacification. 4 stages are defined I, II, III and IV. TDM will be realized only in case of suspicion of fistulas (fever, pain in the left shoulder, vomiting).
The type, the severity and the time between the date of occurrence of fistula and the date of the surgery will be recorded at each visit.
Month 6
Secondary severity of fistula Month 6 The severity of fistula is classified depending on the classification of Montpellier 2013 (Nedelcu) Month 6
Secondary type of fistula Month 12 The diagnosis is confirmed by conducting a CT with contrast medium opacification. 4 stages are defined I, II, III and IV. TDM will be realized only in case of suspicion of fistulas (fever, pain in the left shoulder, vomiting).
The type, the severity and the time between the date of occurrence of fistula and the date of the surgery will be recorded at each visit.
Month 12
Secondary severity of fistula Month 12 The severity of fistula is classified depending on the classification of Montpellier 2013 (Nedelcu) Month 12
Secondary Postoperative morbidity Month 1 Assessed by the type of postoperative complication Month 1
Secondary Postoperative morbidity Month 6 Assessed by the frequency of each type of postoperative complication Month 6
Secondary Postoperative morbidity Month 12 Assessed by the severity of each type of postoperative complication Month 12
Secondary Weight loss Month 1 The evolution of the weight of the patients will be assessed by measuring their weight in kilograms on the same scale at each visit in the digestive surgery service. The height (in meter) will be assessed at baseline in the digestive surgery service. The BMI will be calculated at each visit. Month 1
Secondary Weight loss Month 6 The evolution of the weight of the patients will be assessed by measuring their weight in kilograms on the same scale at each visit in the digestive surgery service. The height (in meter) will be assessed at baseline in the digestive surgery service. The BMI will be calculated at each visit. Month 6
Secondary Weight loss Month 12 The evolution of the weight of the patients will be assessed by measuring their weight in kilograms on the same scale at each visit in the digestive surgery service. The height (in meter) will be assessed at baseline in the digestive surgery service. The BMI will be calculated at each visit. Month 12
Secondary mortality Month 1 number of death Month 1
Secondary mortality Month 6 number of death Month 6
Secondary mortality Month 12 number of death Month 12
Secondary Quality of Life Month 1 : SF 12 Quality of life will be assessed by the self-questionnaire SF12 Month 1
Secondary Quality of Life Month 6 : SF 12 Quality of life will be assessed by the self-questionnaire SF12 Month 6
Secondary Quality of Life Month 12 : SF 12 Quality of life will be assessed by the self-questionnaire SF12 Month 12
Secondary Serious adverse event Month 1 number and type of adverse events Month 1
Secondary safety Month 6: number and type of adverse events number and type of adverse events Month 6
Secondary safety Month 12: number and type of adverse events number and type of adverse events Month 12
See also
  Status Clinical Trial Phase
Completed NCT03657927 - A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients N/A
Recruiting NCT04934826 - Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass N/A
Completed NCT03181347 - The Microbiology of Bariatric Surgery N/A
Completed NCT03886870 - Obesity, Lifestyle and Work Intervention N/A
Active, not recruiting NCT04433338 - The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery N/A
Completed NCT03553849 - Utilization of Very Low Calorie Diet in Obese General Surgery Patients N/A
Completed NCT05854875 - Diabetes Remission After RYGBP and RYGBP With Fundus Resection N/A
Not yet recruiting NCT03203161 - Registry on Obesity Surgery in Adolescents
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Recruiting NCT02129296 - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Phase 1/Phase 2
Active, not recruiting NCT01564732 - Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding N/A
Completed NCT02033265 - Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Not yet recruiting NCT01652105 - Randomized Trial of Preoperative Diets Before Bariatric Surgery N/A
Completed NCT01963637 - Gastric Volumetry by Gastric Tomodensitometry With Gas N/A
Terminated NCT01759550 - Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
Completed NCT01955993 - Fentanyl Metabolism in Obese Adolescents N/A
Completed NCT01149512 - Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program N/A
Recruiting NCT01685177 - Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient N/A
Completed NCT00624624 - Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism N/A
Completed NCT01675713 - Lifestyleintervention for the Treatment of Severe Obesity N/A